title: Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients.
authors: Kidney Centre, Rawalpindi, Pakistan. mhshah@hotmail.com
authors: M H
authors: MH
authors: Shah
authors: M Z M
authors: MZ
authors: Bokhari
authors: M T M
authors: MT
authors: Bokhari
authors: A
authors: A
authors: Farooq
authors: S M
authors: SM
authors: Yousaf
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010154:Pakistan; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D000077552:Basiliximab